Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Top UK Pharma & Biotech Shares
Compare up to 10 stocks
Comparison Results
Name | Price | Volume | Analyst Price Target | Analyst Consensus | Smart Score | Market Cap | P/E Ratio | Dividend Yield | Sector | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AstraZeneca | 11988.00p | 537.00K | xxxxxxxxxxxxx | 9 Buy 4 Hold 0 Sell Moderate Buy | £183.00B | 33.23 | 2.01% | Healthcare | |||
 GlaxoSmithKline | 1444.00p | 1.71M | xxxxxxxxxxxxx | 2 Buy 8 Hold 2 Sell Hold | £58.98B | 22.88 | 4.22% | Healthcare | |||
 Hikma Pharmaceuticals | 2338.00p | 75.68K | xxxxxxxxxxxxx | 4 Buy 2 Hold 0 Sell Moderate Buy | £5.19B | 22.94 | 2.65% | Healthcare | |||
 HUTCHMED (China) Limited | 206.08p | 795.00 | xxxxxxxxxxxxx | 1 Buy 0 Hold 0 Sell Moderate Buy | £1.82B | -54.52 | ― | Healthcare | |||
 | $3866.00 | 192.11K | xxxxxxxxxxxxx | ― | $4.40B | ― | ― |
Performance Comparison
GB:AZN
AstraZeneca
11,802.00
2,408.05
25.63%
GB:GSK
GlaxoSmithKline
1,445.00
-134.80
-8.53%
GB:HIK
Hikma Pharmaceuticals
2,338.00
438.26
23.07%
GB:HCM
HUTCHMED (China) Limited
211.00
-17.00
-7.46%
GB:DPH
―
―
―
―
Pharma & Biotech Latest News
Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.
Recent Analysts Ratings of Pharma & Biotech Stocks
Most Recent Earnings of Pharma & Biotech Stocks
AstraZeneca
Feb 06, 2025
Dec 01, 2024
206
GlaxoSmithKline
Feb 05, 2025
Dec 01, 2024
43.1
Hikma Pharmaceuticals
Aug 08, 2024
Jun 01, 2024
21.4
HUTCHMED (China) Limited
Jul 31, 2024
Jun 01, 2024
-1.443
―
―
―
―
Pharma & Biotech - FAQ
Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
None of the selected stocks have a “Strong Buy” analyst rating consensus.
Are Pharma & Biotech stocks overpriced?
AstraZeneca's stock price is currently 11,988.00p, and its average 12-month price target is 13,681.82p.
GlaxoSmithKline's stock price is currently 1,444.00p, and its average 12-month price target is 1,586.67p.
Hikma Pharmaceuticals's stock price is currently 2,338.00p, and its average 12-month price target is 2,489.17p.
HUTCHMED (China) Limited's stock price is currently 206.08p, and its average 12-month price target is 432.93p.
's stock price is currently 3,866.00, and its average 12-month price target is N/A.
Which Pharma & Biotech stocks pay dividends?
AstraZeneca currently pays a dividend of 168.00p which represents an annual dividend yield of 1.99%. AstraZeneca's next Ex-dividend date is February 20, 2025 and its next payout date is March 24, 2025.
GlaxoSmithKline currently pays a dividend of 16.00p which represents an annual dividend yield of 4.16%. GlaxoSmithKline's next Ex-dividend date is February 20, 2025 and its next payout date is April 10, 2025.
Hikma Pharmaceuticals does not currently pay dividends.
HUTCHMED (China) Limited does not currently pay dividends.
does not currently pay dividends.